Ventolin (Albuterol) Dosage Regimen
Note: "Ventiferon" does not exist as a medication. Based on your question, I am providing dosing information for Ventolin (albuterol/salbutamol), the short-acting beta-agonist bronchodilator.
Acute Bronchospasm Relief
Adults
For acute bronchospasm episodes, administer 2 inhalations (180 mcg) every 4-6 hours as needed 1. In some patients, 1 inhalation every 4 hours may be sufficient 1.
For severe exacerbations requiring emergency department treatment:
- Nebulizer: 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed, or 10-15 mg/hour by continuous nebulization 2
- MDI (90 mcg/puff): 4-8 puffs every 20 minutes up to 4 hours, then every 1-4 hours as needed 2
Children (≥4 years)
For acute bronchospasm, use 2 inhalations every 4-6 hours 1.
For severe exacerbations:
- Nebulizer: 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg/kg up to 10 mg every 1-4 hours as needed, or 0.5 mg/kg/hour by continuous nebulization 2
- MDI: 4-8 puffs every 20 minutes for 3 doses, then every 1-4 hours as needed 2
Exercise-Induced Bronchospasm Prevention
For both adults and children ≥4 years: administer 2 inhalations (180 mcg) 15-30 minutes before exercise 1. This provides protection for approximately 2-4 hours 3.
Critical Caveat on Regular Use
Daily use of albuterol (more than 4 times per week) leads to tolerance, reducing both the duration and magnitude of protection against exercise-induced bronchospasm 3. Tolerance can develop within 12-24 hours of regular use 3. If patients require albuterol more than once daily for exercise, consider adding inhaled corticosteroids rather than increasing SABA frequency 4.
Administration Requirements
Priming
Prime the inhaler by releasing 4 sprays into the air before:
- First use
- Not used for >2 weeks
- After dropping the inhaler 1
Cleaning
Wash the actuator with warm water and air-dry completely at least once weekly to prevent orifice blockage 1.
Important Clinical Considerations
Increasing albuterol use beyond the recommended frequency signals deteriorating asthma control and requires reassessment 1. Regular use exceeding 2 days/week for symptom control (not counting exercise prevention) indicates inadequate disease control and need for controller therapy 5.
MDI with valved holding chamber (spacer) is equally effective as nebulized therapy in mild-to-moderate exacerbations when proper technique is used 2. This is particularly important for children <4 years who should use a face mask with the spacer 2.
For severe exacerbations not responding to initial albuterol therapy, dilute nebulizer solutions to a minimum of 3 mL at gas flow of 6-8 L/min for optimal delivery 2. Albuterol can be mixed with ipratropium in the same nebulizer for severe exacerbations 2.